Background
Methods
Protocol and registration
Eligibility criteria
Search and study selection
Data extraction
Risk of bias assessment
Data synthesis
Results
Search and study selection
Overview of studies
Source, Country | Interventions/Comparatora
| Facility n | Participant n | Study designa
| Type of economic evaluation; analytic viewpoint | Date/source/currency of economic dataa
| Dementia specific | Settinga
|
---|---|---|---|---|---|---|---|---|
Studies of Organisational Characteristics (n = 10) | ||||||||
Arling 1987 [44] United States | Chain-affiliated Independent for-profit Government-owned/not-for-profit | 150 | N/A | Cross-sectional | Cost analysis; Institutional | 1984–1985 ; Medicaid cost reports;
USD
| No | ICF |
Bland 1992 [37] United Kingdom | Government-owned For profit Not-for-profit | Phase 1: 100 Phase 2: 6 | Phase 1: 2,405 Phase 2: 156 | Cross-sectional | Cost analysis; Institutional | 1990; Annual reports, accounts, and individual financial returns;
GBP
| No | RH |
Davis 1993 [41] United States | For profit Not-for-profit | 178 | N/A | Cross-sectional | Cost analysis; Institutional | 1989; Medicaid Certification inspection surveys and cost reports;
USD
| No | NH |
Farsi 2004 [36] Switzerland | Government-owned Not-for-profit | 36 | N/A | Cross-sectional time series | Cost analysis; Institutional | 1993–2001; Annual accounting reports converted to year 2000 Swiss Francs;
CHF
| No | NH |
Holmes 1996 [45] United States | Chain-affiliated Proprietary non-chain Freestanding not-for-profit Government-owned Hospital-based | 393 | N/A | Cross-sectional | Cost analysis; Institutional | 1989; Medicaid Certification inspection surveys and cost reports;
USD
| No | NH |
Smith 1992 [50] United States | Rural location Urban location | 52 | N/A | Cross-sectional | Cost analysis; Institutional | 1987–1988; Medicaid cost reports; research questionnaire to gather performance, strategy, and strategic planning data;
USD
| No | NH |
Sulvetta 1986 [49] United States | Hospital-based Freestanding | 3,492 | N/A | Cross-sectional | Cost analysis; Institutional | 1980; Medicare cost reports, projected to 1983;
USD
| No | SNF |
Ullmann 1984 [46] United States | For profit Not-for-profit Government-owned | 308 | N/A | Cross-sectional | Cost analysis; Institutional | 1977; National Nursing Home Survey;
USD
| No | SNF |
Ullmann 1986 [48] United States | Independent Chain-affiliated | 265 | N/A | Cross-sectional | Cost analysis; Institutional | 1977; National Nursing Home Survey;
USD
| No | SNF |
Ullmann 1987 [47] United States | For profit Not-for-profit Government-owned | 494 | N/A | Cross-sectional | Cost analysis; Institutional | 1976; Source not stated;
USD
| No | SNF |
Studies of Environmental Characteristics (n = 4) | ||||||||
Calkins 2007 [38] United States | Private room s Enhanced shared rooms Traditional shared rooms | N/A | 189 (bedrooms) | Cross-sectional | Cost analysis; Institutional | Date not disclosed.; Standard commercial-grade-construction assumptions for the Cleveland, Ohio area; USD
| No | NH |
Chenoweth 2014 [40] Australia | Person-centred care (PCC) Person-centred environment (PCE) Both PCC + PCE Usual care | 38 | 601 | Cluster Randomised Controlled Trial | Cost analysis; Institutional | 2009–2011; Resource use measured and unit costs assigned using market rates;
AUD
| Yes | RACF |
Jenkens 2011 [39] United States | Green House model Usual care | 7 | N/A | Cross-sectional | Cost analysis; Institutional | 2008; Commercial construction costs sourced from Reed Construction Data; USD
| No | SNF |
Maas 1998 [35]; Swanson 1993 [42]; Swanson 1994 [43] United Statesb
| Special care unit Traditional unit | 1 | 44 | Prospective cohort study | Cost analysis; Health care | Date not disclosed; Resource use measured and unit costs assigned - source of unit cost data not disclosed; USD
| Yes | NH |
Intervention, Study | Outcome | Measurement instrument | Effectiveness results as measured by measurement instrument (baseline; follow-up) |
---|---|---|---|
Proprietary status, Davis 1993 [41] | Composite measure of poor quality based on rates of decubitus ulcers, catheterization, physical restraints, chemical restraints, and drug error rates. | Composite index
Higher scores indicate poorer quality
|
Mean (SD)
For-profit: 0.34 (2.30) Not-for-profit: −0.57 (1.87) |
Person-centred environment (PCE), Chenoweth 2014 [40] | Agitation | Cohen Mansfield Agitation Inventory (CMAI) Higher score indicates greater agitation
|
Mean (95% CI)
Control: 52 (43–61); 51 (41–62) PCE: 65 (57–73); 55 (46–64); p = 0.04 |
Quality of life | DemQol-proxy
Higher score indicates improved quality of life
|
Mean (95% CI)
Control: 101 (98–104); 103 (99–106) PCE: 101 (99–104); 106 (103–109); p = 0.02 | |
Social interactions and behaviour | Care interaction quality (QUIS)
% interactions positive
|
Mean (95% CI)
Control: 78 (73–83); 82 (76–88) PCE: 78 (74–83); 82 (76–87); p = 0.55 | |
Emotional responses in care (ERIC)
% positive
|
Mean (95% CI)
Control: 25 (20–30); 25 (18–31) PCE: 23 (18–28); 26 (21–32); p = 0.63 | ||
Cognitive status | Alzheimer’s Disease Assessment Scale (ADAS)
Cognitive dimension, higher scores indicate lower cognitive ability
|
Mean (SD)
Traditional: 45.38 (15.64); 52.88 (17.89) SCU: 56.67 (12.94); 59.69 (12.95) | |
Social interactions and behaviour | Individual Incident Reports (IIR)
Number of catastrophic reactions
|
Mean (SD)
Traditional: 82; 46 SCU: 156; 48 | |
Function | Functional Abilities Checklist (FAC)
Higher score indicates greater function
|
Mean (SD)
Traditional: 73.67 (15.41); 71.63 (12.25) SCU: 76.15 (12.35); 76.23 (9.76) | |
Geriatric Rating Scale (GRS)
Higher score indicates reduced function
|
Mean (SD)
Traditional: 30.89 (8.18); 35.13 (10.22) SCU: 32.69 (7.76); 35.39 (7.38) |
Organisational characteristics
Proprietary status
Affiliation, size and location
Environmental characteristics
Functional modifications
Home-like environments
Critical appraisal
Source | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 |
---|---|---|---|---|---|---|---|---|---|---|---|
Well-defined question | Comprehensive description of alternatives | All important and relevant costs and outcomes for each alternative identified | Clinical effectiveness established | Costs and outcomes measured accurately | Costs and outcomes valued credibly | Costs and outcomes adjusted for differential timing | Incremental analysis of costs and consequences | Sensitivity analyses conducted | Study results include all issues of concern to users | Results are generalizable | |
Arling 1987 [44] | Yes | Yes | Yes | No | Unclear | Yes | No | No | No | Yes | No |
Bland 1992 [37] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | Unclear |
Davis 1993 [41] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | No |
Farsi 2004 [36] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | Unclear |
Holmes 1996 [45] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | No |
Smith 1992 [50] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | Unclear |
Sulvetta 1986 [49] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | No | Unclear |
Ullmann 1984 [46] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | Unclear |
Ullmann 1986 [48] | Yes | No | Yes | No | Yes | Yes | No | No | No | Yes | Unclear |
Ullmann 1987 [47] | Yes | Yes | Yes | No | Unclear | Yes | No | No | No | Yes | Unclear |
Calkins 2007 [38] | Yes | Yes | Yes | No | Yes | Unclear | No | No | No | No | Yes |
Chenoweth 2014 [40] | Yes | Yes | No | No | Unclear | Yes | No | No | No | No | Unclear |
Jenkens 2011 [39] | Yes | Yes | Yes | No | Yes | Yes | No | No | Yes | Yes | Yes |
Yes | Yes | Yes | No | Unclear | Unclear | No | No | No | No | Unclear |